Lee-Tsai YL, Luna-Santiago R, Demichelis-Gómez R, Ponce-de-León A, Ochoa-Hein E, Tamez-Torres KM, Bourlon MT, Bourlon C. Determining the risk factors associated with the development of Clostridium difficile infection in patients with hematological diseases. Blood Res 2019;54:120-4. [PMID: 31309090 DOI: 10.5045/br.2019.54.2.120][Cited by in Crossref: 2][Cited by in F6Publishing: 1][Article Influence: 0.7][Reference Citation Analysis]
Number
Citing Articles
1
De-la-rosa-martinez D, Rivera-buendía F, Cornejo-juárez P, García-pineda B, Nevárez-luján C, Vilar-compte D. Risk factors and clinical outcomes for Clostridioides difficile infections in a case control study at a large cancer referral center in Mexico. American Journal of Infection Control 2022. [DOI: 10.1016/j.ajic.2022.02.011][Reference Citation Analysis]
2
Yepez Guevara EA, Aitken SL, Olvera AV, Carlin L, Fernandes KE, Bhatti MM, Garey KW, Adachi J, Okhuysen PC. Clostridioides difficile Infection in Cancer and Immunocompromised Patients: Relevance of a Two-step Diagnostic Algorithm and Infecting Ribotypes on Clinical Outcomes. Clin Infect Dis 2021;72:e460-5. [PMID: 32803229 DOI: 10.1093/cid/ciaa1184][Reference Citation Analysis]